← FDA DRUG APPROVALS

FDA ANDA · ANDA213438

HYDROXYUREA

Sponsor: LEADING

APPLICATION
ANDA213438
TYPE
ANDA
ORIGINAL APPROVAL
2020-04-08
LATEST ACTION
2024-04-09
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

HYDROXYUREAPrescription
HYDROXYUREA 500MG · CAPSULE · ORAL

Approval history

2024-04-09Labeling · Supplement 1 · standardAP
2024-04-09Labeling · Supplement 3 · standardAP
2020-04-08UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →